Imidazoquinolinone, Imidazopyridine, and Isoquinolindione Derivatives as Novel and Potent Inhibitors of the Poly(ADP-ribose) Polymerase (PARP): A Comparison with Standard PARP Inhibitors
Eltze, Tobias, Boer, Rainer, Wagner, Thomas, Weinbrenner, Steffen, McDonald, Michelle C, Thiemermann, Christoph, Bürkle, Alexander, Klein, Thomas
Published in Molecular pharmacology (01.12.2008)
Published in Molecular pharmacology (01.12.2008)
Get full text
Journal Article
The Inhibitory Potency and Selectivity of Arginine Substrate Site Nitric-Oxide Synthase Inhibitors Is Solely Determined by Their Affinity toward the Different Isoenzymes
Boer, R, Ulrich, W R, Klein, T, Mirau, B, Haas, S, Baur, I
Published in Molecular pharmacology (01.11.2000)
Published in Molecular pharmacology (01.11.2000)
Get full text
Journal Article
BYK191023 (2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine) Is an NADPH- and Time-Dependent Irreversible Inhibitor of Inducible Nitric-Oxide Synthase
Tiso, Mauro, Strub, Andreas, Hesslinger, Christian, Kenney, Claire T, Boer, Rainer, Stuehr, Dennis J
Published in Molecular pharmacology (01.04.2008)
Published in Molecular pharmacology (01.04.2008)
Get full text
Journal Article
Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock
Pullamsetti, Soni Savai, Maring, Daniel, Ghofrani, Hossein Ardeschir, Mayer, Konstantin, Weissmann, Norbert, Rosengarten, Bernhard, Lehner, Martin, Schudt, Christian, Boer, Rainer, Grimminger, Friedrich, Seeger, Werner, Schermuly, Ralph Theo
Published in Thrombosis and haemostasis (01.04.2006)
Published in Thrombosis and haemostasis (01.04.2006)
Get more information
Journal Article
In Vivo Characterization of the Novel Imidazopyridine BYK191023 [2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine], a Potent and Highly Selective Inhibitor of Inducible Nitric-Oxide Synthase
Lehner, Martin D, Marx, Degenhard, Boer, Rainer, Strub, Andreas, Hesslinger, Christian, Eltze, Manfrid, Ulrich, Wolf-Rüdiger, Schwoebel, Frank, Schermuly, Ralph Theo, Barsig, Johannes
Published in The Journal of pharmacology and experimental therapeutics (01.04.2006)
Published in The Journal of pharmacology and experimental therapeutics (01.04.2006)
Get full text
Journal Article
Characterization of the Dexniguldipine Binding Site in the Multidrug Resistance-Related Transport Protein P-Glycoprotein by Photoaffinity Labeling and Mass Spectrometry
Borchers, Christoph, Boer, Rainer, Klemm, Kurt, Figala, Volker, Denzinger, Thomas, Ulrich, Wolf-Rüdiger, Haas, Sabine, Ise, Wolfgang, Gekeler, Volker, Przybylski, Michael
Published in Molecular pharmacology (01.06.2002)
Published in Molecular pharmacology (01.06.2002)
Get full text
Journal Article
The Novel Imidazopyridine 2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) Is a Highly Selective Inhibitor of the Inducible Nitric-Oxide Synthase
Strub, Andreas, Ulrich, Wolf-Rüdiger, Hesslinger, Christian, Eltze, Manfrid, Fuchss, Thomas, Strassner, Jochen, Strand, Susanne, Lehner, Martin D, Boer, Rainer
Published in Molecular pharmacology (01.01.2006)
Published in Molecular pharmacology (01.01.2006)
Get full text
Journal Article
Novel nanomolar imidazo[4,5-b]pyridines as selective nitric oxide synthase (iNOS) inhibitors: SAR and structural insights
Grädler, Ulrich, Fuchß, Thomas, Ulrich, Wolf-Rüdiger, Boer, Rainer, Strub, Andreas, Hesslinger, Christian, Anézo, Céline, Diederichs, Kay, Zaliani, Andrea
Published in Bioorganic & medicinal chemistry letters (15.07.2011)
Published in Bioorganic & medicinal chemistry letters (15.07.2011)
Get full text
Journal Article
BYK191023 (2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3 H -imidazo[4,5- b ]pyridine) Is an NADPH- and Time-Dependent Irreversible Inhibitor of Inducible Nitric-Oxide Synthase
Tiso, Mauro, Strub, Andreas, Hesslinger, Christian, Kenney, Claire T., Boer, Rainer, Stuehr, Dennis J.
Published in Molecular pharmacology (01.04.2008)
Published in Molecular pharmacology (01.04.2008)
Get full text
Journal Article
The Novel Imidazopyridine 2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3 H -imidazo[4,5- b ]pyridine (BYK191023) Is a Highly Selective Inhibitor of the Inducible Nitric-Oxide Synthase
Strub, Andreas, Ulrich, Wolf-Rüdiger, Hesslinger, Christian, Eltze, Manfrid, Fuchß, Thomas, Strassner, Jochen, Strand, Susanne, Lehner, Martin D., Boer, Rainer
Published in Molecular pharmacology (01.01.2006)
Published in Molecular pharmacology (01.01.2006)
Get full text
Journal Article
O34. Potent and highly selective inhibition of the inducible nitric oxide synthase in vitro and in vivo by the novel imidazopyridine BYK191023
Strub, Andreas, Hesslinger, Christian, Lehner, Martin D., Ulrich, Wolf-Rüdiger, Eltze, Manfrid, Fuchß, Thomas, Boer, Rainer
Published in Nitric oxide (01.06.2006)
Published in Nitric oxide (01.06.2006)
Get full text
Journal Article
In Vivo Characterization of the Novel Imidazopyridine BYK191023 [2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3 H -imidazo[4,5- b ]pyridine], a Potent and Highly Selective Inhibitor of Inducible Nitric-Oxide Synthase
Lehner, Martin D., Marx, Degenhard, Boer, Rainer, Strub, Andreas, Hesslinger, Christian, Eltze, Manfrid, Ulrich, Wolf-Rüdiger, Schwoebel, Frank, Schermuly, Ralph Theo, Barsig, Johannes
Published in The Journal of pharmacology and experimental therapeutics (01.04.2006)
Published in The Journal of pharmacology and experimental therapeutics (01.04.2006)
Get full text
Journal Article
O66. The highly selective iNOS inhibitor BYK402750 exerts potent anti-inflammatory effects in a mouse model of cigarette smoke-induced inflammation
Hesslinger, Christian, Lehner, Martin D., Strub, Andreas, Boer, Rainer, Ulrich, Wolf-Ruediger, Kuelzer, Raimund, Lauer, Gereon, Liu, Dan, Spicer, Diane, Fitzgerald, Mary, Wollin, Lutz, Weidenbach, Andreas
Published in Nitric oxide (2008)
Published in Nitric oxide (2008)
Get full text
Journal Article
45- IMIDAZO[45-B]PYRIDINE-DERIVATIVES AS INDUCIBLE NO-SYNTHASE INHIBITORS
GRAEDLER ULRICH, ULRICH WOLF RUEDIGER, BOER RAINER, ELTZE MANFRID, FUCHSS THOMAS, MARX DEGENHARD
Year of Publication 22.08.2006
Get full text
Year of Publication 22.08.2006
Patent
In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic α 1A - vs. α 1B - and α 1D -adrenoceptors
Eltze, Manfrid, Boer, Rainer, Michel, Martin, Hein, Peter, Testa, Rodolfo, Ulrich, Wolf-Rüdiger, Kolassa, Norbert, Sanders, Karl
Published in Naunyn-Schmiedeberg's archives of pharmacology (22.05.2001)
Published in Naunyn-Schmiedeberg's archives of pharmacology (22.05.2001)
Get full text
Journal Article
Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistance
Hofmann, Johann, Gekeler, Volker, Ise, Wolfgang, Noller, Andrea, Mitterdorfer, Jörg, Hofer, Susanne, Utz, Irene, Gotwald, Markus, Boer, Rainer, Glossmann, Hartmut, Grunicke, Hans H.
Published in Biochemical pharmacology (01.03.1995)
Published in Biochemical pharmacology (01.03.1995)
Get full text
Journal Article
Dexniguldipine-HCl is a potent allosteric inhibitor of [ 3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells
Malkhandi, Joy, Ferry, David R., Boer, Rainer, Gekeler, Volker, Ise, Wolfgang, Keer, David J.
Published in European journal of pharmacology (15.12.1994)
Published in European journal of pharmacology (15.12.1994)
Get full text
Journal Article
Rhodamine 123 efflux modulation in the presence of low or high serum from CD56 + hematopoietic cells or CD34 + leukemic blasts by B9309-068, a newly designed pyridine derivative
Beck, James Friedrich, Buchholz, Frank, Ulrich, Wolf-Rüdiger, Boer, Rainer, Sanders, Karl Heinrich, Niethammer, Dietrich, Gekeler, Volker
Published in Cancer letters (17.07.1998)
Published in Cancer letters (17.07.1998)
Get full text
Journal Article